Tris Pharma Announces Publication of Study Results Highlighting the Efficacy and Safety of DYANAVEL® XR (amphetamine) Tablets for the Treatment of the Symptoms of ADHD in Adults
Tris announces the publication of a Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose Study of DYANAVEL XR Tablets in Adults with ADHD in the Journal of...
Tris Pharma Inc Prnewswire Tris Pharma Inc Fixed Dose Study Clinical Psychiatry Permanent Product Measure Tris Pharma
Source: prnewswire.com